A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
Public ClinicalTrials.gov record NCT00942604. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Parallel Group, Double-blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, 0.05%, In Patients With Actinic Keratoses on Non-head Locations (REGION-Ib)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
Study identification
- NCT ID
- NCT00942604
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 203 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2009
- Primary completion
- Sep 30, 2009
- Completion
- Sep 30, 2009
- Last update posted
- Mar 5, 2015
2009
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arizona | 71913 | — |
| Skin Surgery Medical Group Inc. | San Diego | California | 92117 | — |
| Atlanta Dermatology, Vein & Research Center, LLC | Alpharetta | Georgia | 30022 | — |
| Altman Dermatology Associates | Arlington Heights | Illinois | 60005 | — |
| Glazer Dermatology | Buffalo Grove | Illinois | 60089 | — |
| Deaconess Clinic Downtown | Evansville | Indiana | 47713 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| Karl G. Heine Dermatology | Henderson | Nevada | 89002 | — |
| Group Health Associates | Cincinnati | Ohio | 45220 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| Suzanne Bruce and Associates, PA, The Center for Skin Research | Houston | Texas | 77056 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
| Dermatology Associates of Tyler | Tyler | Texas | 75703 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84124 | — |
| The Education and Research Foundation | Lynchburg | Virginia | 24501 | — |
| Virginia Clinical Research, Inc | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00942604, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2015 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00942604 live on ClinicalTrials.gov.